Abbott ABT Diagnostic Products — Operating Earnings
Other segment segments
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's diagnostic products — operating earnings.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Abbott's diagnostic products — operating earnings?
- Abbott (ABT) reported diagnostic products — operating earnings of $335M in Q1 2026.
- How has Abbott's diagnostic products — operating earnings changed year-over-year?
- Abbott's diagnostic products — operating earnings decreased by 6.7% year-over-year, from $359M to $335M.
- What is the long-term trend for Abbott's diagnostic products — operating earnings?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — operating earnings has grown at a -27.3% compound annual growth rate (CAGR), from $6.24B to $1.74B.
- What does diagnostic products — operating earnings mean?
- Profit from the diagnostics business before interest and taxes.
- How do you interpret diagnostic products — operating earnings?
- Higher earnings indicate strong operational performance and effective cost control within the segment.
- How does diagnostic products — operating earnings compare across companies?
- Standard segment-level operating profit metric.